The Cooper Companies, Inc. (COO) is well-poised for growth, backed by strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company’s portfolio and buoy optimism. However, unfavorable currency movements and rising costs continue to hurt revenues and margins, respectively.Shares of this currently Zacks Rank #2 (Buy) company have risen 15.5% in the past six months compared with the industry's 3.8% growth. The S&P 500 Index has gained 13.4% in the same ti ...